SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. - Wikidata - wikimedia - TriplyDB

SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

http://www.wikidata.org/entity/Q39811582

about

Clinical relevance of SKP2 alterations in metastatic melanoma RASSF tumor suppressor gene family: biological functions and regulation HULC: an oncogenic long non-coding RNA in human cancer Mature mice lacking Rbl2/p130 gene have supernumerary inner ear hair cells and supporting cells.GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function.Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.Regulation of FOXO protein stability via ubiquitination and proteasome degradation.DCGL v2.0: an R package for unveiling differential regulation from differential co-expression Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21 SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice.Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex.Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma.Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion.New insights on the role of epigenetic alterations in hepatocellular carcinoma.Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression.Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B Cks1: Structure, Emerging Roles and Implications in Multiple Cancers Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma.Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells.MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells.Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells.Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription.Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo.Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.

P2860

Q24630149-7ADF5C96-0F6F-4DF6-8DF6-F1C30DB0255E Q26866080-9E6F1797-C702-4614-91DE-9A7A6E424B8E Q28076430-01BEF49C-0CE2-40E5-96EC-AE8D23A2E175 Q30472107-23C9AD56-1B3F-42A8-83D3-3D4CE0826525 Q33894926-00A1573F-4369-4B03-9C25-30A140077CBF Q34298501-E202020E-3062-4AC6-AFA2-83D21A0D54F6 Q34487963-89749618-BC33-4372-B864-6092DF368FBE Q35032366-80883AFC-168A-4A0C-A0C2-4EA6C1DA1677 Q35053226-63840DDF-B489-4A30-8D6E-8AEAE23ACB3A Q35269350-BDB878D8-8341-4D89-AE3D-E84AC0A5633C Q35273519-F59EB214-B293-4413-A0F6-A2017EA4DA13 Q35943932-E625FEA5-FE27-4A44-B73C-ADA3A6FB8B89 Q35944703-DC1266DB-E607-4575-B0E5-790878AF1D08 Q36551702-9B67EB5B-310D-4A35-BF33-FDF43BEE64E6 Q37031728-6B1826F9-B84E-4370-8E55-F3B5F788F21E Q37322983-161A1A89-5928-4BC2-895E-7EA1D0D30DF6 Q37363966-E34500C8-2E13-450A-9009-BDEE2A225C7C Q37536593-491C0C98-AB84-42E2-BE5A-AE1B76C9B1E5 Q37595393-BAA50E6F-35A4-477E-B97B-98C02214E499 Q37680723-05AFE58E-2F2E-49A0-9918-1C0E46138EF9 Q37702154-0DC5D562-646F-4EBA-A7DF-E123CF78A465 Q37777019-C9A2BB5C-FBD7-4F82-B940-F8514EDA3E9F Q38084210-3E344A6B-5AFB-4A35-86A2-E3836F0604B9 Q38178032-47B74883-045D-46DB-9708-E6A2A2DF625E Q38178169-4E8A23B2-965A-441E-B256-E88D1727509A Q38295509-27512ADA-6070-4035-830E-597C8D473565 Q38726399-F3251F4F-A1AC-4F99-A897-53B535CD1F14 Q38816822-D7F6F2C8-BC3D-4B37-B0F5-1012FC5FDF86 Q38823288-190EB7F9-C6A6-456B-9C00-4A29C1812158 Q38906745-5B7E3291-972C-4968-9F23-30A64A586C1E Q38922362-5B16FDD9-5459-490C-B468-F26505AB32E4 Q38925021-BE38391E-AC09-47C7-95BE-E3AA2A668EB7 Q38928694-ACACF31F-1C3D-4AFC-9003-9C3AE0BC0EBB Q38948216-02B10A1A-ECBD-4227-9CF6-CA296442A993 Q39165661-3D668051-3111-400A-8868-5A6AF0B58ADF Q39205216-1BC57099-C518-4735-86E9-D46408874636 Q39228469-F6663C97-F281-4F85-A157-D031FFF98A9A Q39289102-A47A37E3-5C05-46D2-B796-AEB774434D49 Q39361933-AAE90052-D560-40BF-BEE3-5D58B347DB86 Q39529179-54DB0D2C-983E-474F-83C6-6DFD52250A05

P2860

SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

http://www.wikidata.org/entity/Q39811582

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

SKP2 and CKS1 promote degradat ...... ocellular carcinoma prognosis.

@en

SKP2 and CKS1 promote degradat ...... ocellular carcinoma prognosis.

@nl

type

label

SKP2 and CKS1 promote degradat ...... ocellular carcinoma prognosis.

@en

SKP2 and CKS1 promote degradat ...... ocellular carcinoma prognosis.

@nl

prefLabel

SKP2 and CKS1 promote degradat ...... ocellular carcinoma prognosis.

@en

SKP2 and CKS1 promote degradat ...... ocellular carcinoma prognosis.

@nl

P1433

Q39811582-2031ED5D-A183-4195-953C-81FEE57594A3

P1476

Q39811582-1FD42F72-6FBE-4346-899C-9B8CE7588E49

P2093

Q39811582-207DD88E-63BE-4F26-9A27-D60A376E6955

Q39811582-3A8636E2-6A4F-48EA-9069-674882292655

Q39811582-6A5D7563-91FC-4115-AF54-8BE7B7D50C10

Q39811582-6E082AE8-7029-4E3D-A156-B03B65A7EE28

Q39811582-748C62CD-2DCC-4372-81F7-657795EEA415

Q39811582-817F5B0B-883B-4549-AD2F-0D674A8E1933

Q39811582-A1AC0E0F-5B62-499C-89BF-E88F0D1F699F

Q39811582-BE98E627-92DD-4306-AFDB-03595FEBE6CA

Q39811582-BF39A8BB-A2BA-4892-A1B5-74093A9484AC

Q39811582-C5F56D90-B2D6-439E-BF66-21386433ECD7

P304

Q39811582-B86E670F-CE55-4C30-8E1F-256A160960AB

P31

Q39811582-2639C019-7CD4-477A-951D-C616277B8A48

P356

Q39811582-54F57D70-C372-403D-BBBC-DBD622400FD8

P407

Q39811582-786FDC19-5FFF-4502-8D9E-4A6A542718A2

P433

Q39811582-ADAD5E26-3330-4121-8CB7-1053E50C35E9

P478

Q39811582-A0196076-A1A1-4859-9F81-5A0B9382717A

P50

Q39811582-B9C90015-D80D-4CD4-A596-5AC1D9F7EBF7

P577

Q39811582-B823FC6F-3350-4CFF-8638-B2C7835BE72D

P5875

Q39811582-D65947CC-9A12-4970-9BD3-C6F56AF7E31F

P698

Q39811582-BDD87A4D-C299-4598-B004-A3E87B547A27

P356

J.GASTRO.2009.08.005

P1433

Gastroenterology

P1476

SKP2 and CKS1 promote degradat ...... ocellular carcinoma prognosis.

@en

P2093

Diego F Calvisi

http://www.w3.org/2001/XMLSchema#string

Federico Pinna

http://www.w3.org/2001/XMLSchema#string

Francesco Feo

http://www.w3.org/2001/XMLSchema#string

Maddalena Frau

http://www.w3.org/2001/XMLSchema#string

Marcella Sini

http://www.w3.org/2001/XMLSchema#string

Maria A Seddaiu

http://www.w3.org/2001/XMLSchema#string

Maria L Tomasi

http://www.w3.org/2001/XMLSchema#string

Maria M Simile

http://www.w3.org/2001/XMLSchema#string

Maria R Muroni

http://www.w3.org/2001/XMLSchema#string

Piero Bonelli

http://www.w3.org/2001/XMLSchema#string

P304

1816-26.e1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2009.08.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26747814

http://www.w3.org/2001/XMLSchema#string

P698

19686743

http://www.w3.org/2001/XMLSchema#string